文献速递前列腺癌肾癌与肾肿瘤膀胱癌与上尿路尿路上皮癌

睾丸转移性肿瘤的来源与结局:一项全国性研究

Origin and outcome of metastatic tumours to the testes: a nationwide study.
PubMed 文献 · BJU Int · 2023-11-10

该研究基于荷兰全国病理数据库和癌症登记库,对1991年至2021年间病理确诊的175例睾丸转移性肿瘤患者进行回顾性队列分析。结果显示睾丸转移最常来源于前列腺(40.6%)、肾(13.7%)、结肠(10.3%)、膀胱(7.4%)和皮肤(5.7%),诊断后中位总生存期仅14.2个月(95%CI 10.2-18.3),原发肿瘤来源是独立预后因素。

要点

  • 睾丸转移性肿瘤极罕见,主要来源于解剖上邻近睾丸的原发肿瘤。
  • 多数患者在原发癌诊断后中位22个月出现异时性转移,处于寡转移阶段。
  • 诊断睾丸转移后中位总生存期仅14.2个月,皮肤、膀胱和结肠来源者生存最差。

核心结论

  • 睾丸转移性肿瘤非常罕见,主要来源于解剖上邻近睾丸的原发肿瘤。
  • 多数患者在原发癌诊断后异时性出现睾丸转移,处于寡转移性疾病阶段。
  • 这类转移 invariably 与不良生存相关。

研究设计与样本

  • 全国性回顾性队列分析,检索1991年至2021年荷兰全国病理数据库(PALGA)和荷兰癌症登记库中病理确诊的睾丸转移患者,共纳入175例。
  • 采用对数秩检验和Kaplan-Meier分析评估总生存期,Cox比例风险模型进行多因素生存分析。

主要发现

  • 诊断睾丸转移时的中位(范围)年龄为67(3-88)岁。
  • 原发肿瘤最常见为前列腺(40.6%)、肾(13.7%)、结肠(10.3%)、膀胱(7.4%)和皮肤(5.7%)。
  • 53例为同时性睾丸转移,114例为异时性病变,异时性转移出现在原发癌诊断后中位(四分位距)22(1-53)个月。
  • 诊断睾丸转移后总生存期差,中位生存期为14.2个月(95%CI 10.2-18.3)。
  • 原发肿瘤来源是生存的独立因素,皮肤、膀胱和结肠原发癌患者生存最差。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To perform a retrospective cohort analysis for metastatic tumours in the testes to explore the timing, presentation and prognosis of this particular type of metastases and the factors that influence outcome. PATIENTS AND METHODS: A nationwide retrospective review of pathology reports of patients with pathologically confirmed metastases to the testis between 1991 and 2021 was performed. Data were collected from the Dutch nationwide pathology databank (PALGA) and the Netherlands Cancer Registry. Log-rank testing and Kaplan-Meier analyses were used to assess overall survival (OS), and Cox proportional hazard models were used for multivariate survival analysis. RESULTS: A total of 175 patients with a testicular metastasis were included. The median (range) age at diagnosis of testicular metastasis was 67 (3-88) years. Testicular metastases originated from a variety of primary tumours, although most frequently from the prostate (40.6%), kidney (13.7%), colon (10.3%), bladder (7.4%) and skin (5.7%). Synchronous testicular metastasis was detected in 53 cases, while 114 metachronous lesions were found after a median (interquartile range) interval of 22 (1-53) months after the original cancer diagnosis. OS after the diagnosis of a testicular metastasis was poor, with a median survival of 14.2 months (95% confidence interval 10.2-18.3). Primary tumour origin was an independent factor for survival, with worst survival for patients with primary skin, bladder and colon cancer. CONCLUSION: Testicular metastases are very uncommon and arise mainly from primary tumours anatomically close to the testes. Most patients develop metachronous testicular metastasis at an oligometastatic disease stage. These metastases are invariably associated with poor survival.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Woortman C, van Leenders GJLH, Hugen N, et al. Origin and outcome of metastatic tumours to the testes: a nationwide study. BJU Int. 2023. PMID: 37877215. doi:10.1111/bju.16212

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。